1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998. 279:1200–1205.
Article
2. World Health Organization. WHO Collaborating Center for International Drug Monitoring. The importance of pharmacovigilance. 2002. Geneva: World Health Organization.
3. Kohn LT, Corrigan J, Donaldson MS. Institute of Medicine (US) Committee on Quality of Health Care in America. To err is human: building a safer health system. 2000. Washington, DC: National Academy Press.
4. Korean Society for Pharmacoepidemiology and Risk Management. Korean Society for Pharmacoepidemiology and Risk Management. Concept of risk management. Pharmacoepidemiology. 2011. Seoul: Seoul National University Press;10–15.
5. Graham DJ, Mosholder AD, Gelperin K, Avigan MI. Strom BL, editor. Pharmacoepidemiology and risk management. Pharmacoepidemiology. 2005. 4th ed. Hoboken: John Wiley & Sons;515–530.
Article
8. Center for Drug Evaluation and Research (US). Center for Biologics Evaluation and Research (US). Guidance for industry: format and content of proposed risk evaluation and mitigation strategies (REMS), REMS assessments, and proposed REMS modifications. 2009. Rockville (MD): US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research.